Interestingly, temporary lesions to the pre-SMA resulted in reduced tone binding with no effect on action binding.
We performed two complementary analyses, submitting action and tone binding measures to a mixed-design ANOVA.
The mean time estimation shifts in operant conditions were separately compared against the corresponding baseline conditions to obtain action and tone binding measures, respectively.
However, such abnormal prediction process is also likely to have an impact on tone binding (Waszak et al., 2012; Wolpe et al., 2013), which we did not observe.
In contrast, cue integration is unlikely to support tone binding (Wolpe et al., 2013), where unreliable cues are compensated by another mechanism (Waszak et al., 2012), which might be spared in CBS.
Our current results can neither exclude a retrospective binding component in "action + tone" trials when the action – outcome delay is fixed, nor, indeed, in "action only" trials, as the omission of an expected outcome in these trials may well constitute a sensory event (Sutton, Tueting, Zubin, & John, 1967) and thus alter action awareness retrospectively.
In this study, we describe the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway involved in the taurine-regulated TauT expression in ischemic CMs.
Between the two deletion constructs, pTauT/-99-Luc with a deletion of the proximal TonE region (TonEBP-binding site) markedly decreased luciferase activity compared with the pTauT/-124-Luc reporter construct.
Testosterone increased action binding but there was no significant effect on tone binding.
It causes vascular smooth muscle relaxation by binding to guanyl cyclase hence maintaining basal vasomotor tone.
